Change Control Audit Readiness
Verify your change control system is documented, risk-assessed, and inspection-ready
Overview
What's Inside
Change control is a foundational element of pharmaceutical quality systems. Every change to processes, equipment, facilities, materials, or documentation must be formally evaluated for impact, risk-assessed, approved by authorised personnel, and monitored after implementation. FDA investigators routinely review change control records to assess whether a site manages change proactively or reactively.
This checklist covers six key domains: change control documentation and record accuracy; process and system reviews including impact analysis, implementation verification, and training; regulatory compliance evaluation and quality risk management integration; equipment and facility change documentation; communication, coordination, and pre-implementation readiness review; and post-implementation follow-up with monitoring and continuous improvement.
Each section includes Yes/No/NA audit questions aligned with FDA, EU GMP, and WHO GMP expectations. Use it to ensure changes are initiated properly, risk-assessed thoroughly, implemented according to documented procedures, and verified for effectiveness after go-live.
Why It Matters
Uncontrolled or poorly documented changes are a direct path to 483 observations. FDA investigators look for evidence that every change was risk-assessed before implementation, that impact on product quality and compliance was evaluated, and that post-implementation reviews confirmed the change achieved its intended outcome. Missing any of these steps signals a quality system gap.
What's Covered
Sections in this checklist
- Change control procedures, records, and approval documentation
- Risk assessment conduct, documentation, and periodic review
- Impact analysis on product quality, safety, and compliance
- Change implementation verification and training requirements
- Regulatory compliance evaluation (FDA, EU GMP, WHO GMP)
- Equipment and facility change documentation and calibration updates
- Communication protocols, stakeholder involvement, and pre-implementation review
- Post-implementation monitoring, deviation tracking, and continuous improvement
Who It's For
Target roles
Regulatory Basis
21 CFR 211.100, ICH Q10, EU GMP Chapter 1, WHO GMP Annex 4, FDA Compliance Program 7356.002
Download Change Control Audit Readiness
Enter your details once to unlock all Audit Hub resources. All future downloads are instant.
Related Checklists
Complaint Management Audit Readiness
End-to-end audit readiness checklist for pharmaceutical complaint management systems, covering complaint investigation thoroughness, root cause analysis, retain sample testing, CAPA linkage, and trending analysis aligned with FDA 483 focus areas.
CAPA Management Audit Readiness
Audit readiness checklist for CAPA systems covering initiation timeliness, root cause analysis quality, effectiveness checks, recurrence prevention, and management review integration — built from real FDA 483 observation patterns.
Quality Risk Management Audit Readiness (ICH Q9)
Comprehensive 100-point QRM audit checklist spanning all six FDA systems plus documentation, training, complaint management, and continuous improvement — structured as Yes/No/NA self-assessment questions aligned with ICH Q9 and ICH Q10.
Leucine is the first AI-native platform built for pharmaceutical manufacturing. It unifies quality management, regulatory compliance, and production operations into one intelligent system that powers your entire drug manufacturing lifecycle from raw materials to patient delivery.
